How Catalyst Health Ventures Found A Sweet Spot In Early-Stage MedTech
Catalyst Health Ventures, a $225 million Medtech-focused VC firm, has carved out a niche by investing in early-stage medical devices, a sector many venture capitalists have shied away from. Despite a challenging funding landscape where capital has shifted towards later-stage deals, Catalyst continues to support unproven medical innovations. Their focus is on the patient impact, citing examples of devices that have saved lives or significantly improved patient diagnoses and treatment. AI
IMPACT Focuses on venture capital investment trends in medical devices, not directly on AI capabilities or releases.